ZA200709631B - Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics - Google Patents

Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics

Info

Publication number
ZA200709631B
ZA200709631B ZA200709631A ZA200709631A ZA200709631B ZA 200709631 B ZA200709631 B ZA 200709631B ZA 200709631 A ZA200709631 A ZA 200709631A ZA 200709631 A ZA200709631 A ZA 200709631A ZA 200709631 B ZA200709631 B ZA 200709631B
Authority
ZA
South Africa
Prior art keywords
immunotherapeutics
antibodies
methods
combination
treating cancer
Prior art date
Application number
ZA200709631A
Inventor
Alan J Korman
Wang Changyu
Chen Bing
Srinivasan Mohan
Mark J Selby
Josephine M Cardarelli
Original Assignee
Ono Pharmaceutical Co
Medarex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co, Medarex Inc filed Critical Ono Pharmaceutical Co
Publication of ZA200709631B publication Critical patent/ZA200709631B/en

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
ZA200709631A 2005-05-09 2007-11-08 Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics ZA200709631B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67946605P 2005-05-09 2005-05-09

Publications (1)

Publication Number Publication Date
ZA200709631B true ZA200709631B (en) 2008-11-26

Family

ID=39612503

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200709631A ZA200709631B (en) 2005-05-09 2007-11-08 Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics

Country Status (1)

Country Link
ZA (1) ZA200709631B (en)

Similar Documents

Publication Publication Date Title
HUS1500067I1 (en) Human monoclonal antibodies to programmed death 1(PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics
IL255078A0 (en) Antibodies that bind transforming growth factor beta for use in treating cancer
EP1793858A4 (en) Human monoclonal anti-ctla4 antibodies in cancer treatment
IL231169A0 (en) Human monoclonal antibodies to fucosyl-gm1 and methods for using anti-fucosyl-gm1
IL188124A0 (en) Human monoclonal antibodies to programmed death ligand 1 (pd-l1)
IL179891A (en) Antibodies and immunoconjugates that bind to cd44e and methods and uses thereof
ZA200801190B (en) Anti-CTLA-4 antibody and CpG-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatment
ZA200710975B (en) Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (pd-1) pathway
EP2103628A4 (en) Anti-claudin-3 monoclonal antibody, and treatment and diagnosis of cancer using the same
ZA200708575B (en) Methods and compositions for treating or preventing cancer
SI2066349T1 (en) Humanized anti-cd19 antibodies and their use in treatment of tumors, transplantation and autoimmune diseases
ZA200709631B (en) Human monoclonal antibodies to programmed death 1 (PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics
SI2161336T2 (en) Human monoclonal antibodies to programmed death 1(PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics
HK1201043A1 (en) Sodium meta arsenite for use in the treatment of pain and or inflammation associated with cancer